Capricor Therapeutics Inc.

In News

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - PR Newswire

PR Newswire - Aug 29, 2026

Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit Seeks Recovery for Investors; September 28, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP - Morningstar

Morningstar - Aug 27, 2026

When Will Capricor Therapeutics, Inc. (NASDAQ:CAPR) Breakeven? - Moomoo

Moomoo - Aug 26, 2026

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 - Barchart.com

Barchart.com - Aug 28, 2026

Capricor Therapeutics Announces Extension of PDUFA Target - GlobeNewswire

GlobeNewswire - Aug 24, 2026

Capricor's Duchenne drug gets three-month FDA extension after new data submission - Reuters

Reuters - Aug 24, 2026

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights - NewMediaWire

NewMediaWire - Aug 27, 2026

CAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review - Stocktwits

Stocktwits - Aug 28, 2026

Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026 - The Globe and Mail

The Globe and Mail - Aug 25, 2026

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline - PR Newswire

PR Newswire - Aug 28, 2026

Deadline Alert: Capricor Therapeutics, Inc. (CAPR) - GlobeNewswire

GlobeNewswire - Aug 25, 2026

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky - PR Newswire

PR Newswire - Aug 26, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment